Back
Windtree Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
WINT
Windtree Therapeutics
Last Price:
0.49
Seasonality Move:
-6.99%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.5 | Buy |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 1.37 | Sell |
| 200-day SMA: | 4.73 | Sell |
| 8-day EMA: | 0.52 | Sell |
| 20-day EMA: | 0.68 | Sell |
| 50-day EMA: | 1.73 | Sell |
| 200-day EMA: | 10.76 | Sell |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 28.37 | Sell |
| Chaikin Money Flow: | 65293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.86) | Sell |
| Bollinger Bands (100): | (0.34 - 7.9) | Sell |
Windtree Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.51 while WINT 8-day simple moving average is 0.50, which is a Buy signal.
- The stock price of WINT is 0.51 while Windtree Therapeutics 20-day SMA is 0.63, which makes it a Sell.
- Windtree Therapeutics 50-day simple moving average is 1.37 while WINT share price is 0.51, making it a Sell technically.
- WINT stock price is 0.51 and Windtree Therapeutics 200-day simple moving average is 4.73, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
17
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a Sell
The current Windtree Therapeutics [WINT] share price is $0.51. The Score for WINT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
301.5K
Price in USD:
0.51
Share Volume:
227.77K
Windtree Therapeutics 52-Week Range
52-Week High:
22.36
52-Week Low:
0.45
Sell
17
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?
The Windtree Therapeutics stock price is 0.51 USD today. -
Will WINT stock go up or go down?
Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Windtree Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.51 while WINT 8-day exponential moving average is 0.52, which is a Sell signal.
- The stock price of WINT is 0.51 while Windtree Therapeutics 20-day EMA is 0.68, which makes it a Sell.
- Windtree Therapeutics 50-day exponential moving average is 1.73 while WINT share price is 0.51, making it a Sell technically.
- WINT stock price is 0.51 and Windtree Therapeutics 200-day simple moving average is 10.76, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $92.48 per share, and an increase next year of $0.25 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
- WINT Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Windtree Therapeutics is a Sell
- Windtree Therapeutics Relative Strength Index (RSI) is 28.37, which suggest Windtree Therapeutics is oversold
- The Bollinger Bands (25) for Windtree Therapeutics is (0.52 - 0.86), which suggest Windtree Therapeutics is a Sell
- The Bollinger Bands (100) for Windtree Therapeutics is (0.34 - 7.9), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.